Nuvation Bio (NUVB) Goodwill & Intangibles (2024 - 2026)
Nuvation Bio (NUVB) posted quarterly Goodwill & Intangibles of $10.8 million for Q1 2026, up 143.88% year-over-year from $4.4 million in Q1 2025, and down 4.09% quarter-over-quarter from $11.2 million in Q4 2025.
Nuvation Bio (NUVB) Goodwill & Intangibles (2024 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Goodwill & Intangibles for 3 consecutive years, with $10.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 143.88% year-over-year to $10.8 million; the TTM figure through Mar 2026 stood at $10.8 million (up 143.88% YoY), while the FY2025 annual figure was $11.2 million, up 142.62% from the prior year.
- Goodwill & Intangibles retreated to $10.8 million in Q1 2026 per NUVB's latest filing, from $11.2 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $12.1 million in Q2 2025 and bottomed at $2.8 million in Q3 2024.
- Historically, Goodwill & Intangibles has averaged $7.6 million across 3 years, with a median of $7.7 million in 2024.
- On a YoY basis, Goodwill & Intangibles climbed as much as 320.3% in 2025 and fell as far as 142.62% in 2025.
- Nuvation Bio's Goodwill & Intangibles stood at $4.6 million in 2024, then jumped by 142.62% to $11.2 million in 2025, then slipped by 4.09% to $10.8 million in 2026.
- Business Quant data shows NUVB's Goodwill & Intangibles at $10.8 million in Q1 2026, $11.2 million in Q4 2025, and $11.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.29 Mn |
| Mar 31, 2026 | 10.76 Mn |
| Dec 31, 2025 | 11.21 Mn |
| Sep 30, 2025 | 11.68 Mn |
| Jun 30, 2025 | 12.15 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 2.78 Mn |
| Jun 30, 2024 | 2.93 Mn |